ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CSTL Castle Biosciences Inc

22.15
0.87 (4.09%)
Mar 28 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 380,402
Bid Price 21.17
Ask Price 22.85
News -
Day High 22.52

Low
9.2601

52 Week Range

High
26.70

Day Low 21.33
Company Name Stock Ticker Symbol Market Type
Castle Biosciences Inc CSTL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.87 4.09% 22.15 20:00:00
Open Price Low Price High Price Close Price Prev Close
21.37 21.33 22.52 22.15 21.28
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
4,433 380,402 $ 22.27 $ 8,470,403 - 9.2601 - 26.70
Last Trade Time Type Quantity Stock Price Currency
17:38:06 20 $ 22.15 USD

Castle Biosciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
608.02M 27.45M - 219.79M -57.47M -2.09 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Castle Biosciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CSTL Message Board. Create One! See More Posts on CSTL Message Board See More Message Board Posts

Historical CSTL Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week20.5222.5220.1221.02206,3711.637.94%
1 Month24.8524.873917.4220.16314,149-2.70-10.87%
3 Months20.8325.6017.4221.57257,9481.326.34%
6 Months16.4125.6012.0719.27263,5175.7434.98%
1 Year22.4226.709.260117.87384,918-0.27-1.20%
3 Years59.1978.929.260129.77283,563-37.04-62.58%
5 Years20.00107.699.260134.68254,6472.1510.75%

Castle Biosciences Description

Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.

Your Recent History

Delayed Upgrade Clock